Robert I. Kelly is a rheumatologist based in Fitzroy, VIC, working at St Vincent's Hospital Melbourne. Rheumatology is the branch of medicine that looks after long-term problems with joints, muscles, and the immune system.
In day-to-day care, Robert focuses on inflammatory conditions where the body’s immune system can affect blood vessels and the skin. Some patients come in with things like vasculitis, where there’s inflammation in the small or medium blood vessels. Others may have skin changes that can look different from person to person, but still link back to immune and inflammatory causes.
This can include conditions such as lymphocytic vasculitis, polyarteritis nodosa, and purpura. At times, skin lumps, painful spots, or ongoing rashes are part of the picture too, including erythema nodosum, livedo reticularis, and granuloma annulare. In some cases, people also need help with problems like pyoderma gangrenosum, which can be painful and slow to settle.
Robert also sees patients with rarer immune-related conditions, including adenosine deaminase 2 deficiency. These cases can be tricky because symptoms may come and go, and tests can take time. Over time, the goal is to work out what is driving the inflammation, then help keep symptoms under control with the right treatment plan.
Because this sort of care often needs careful monitoring, Robert looks at the whole situation, not just the flare on the day. Blood tests, scans if needed, and skin or biopsy results may all play a part. The plan is usually built around steady, practical steps—things that can be followed in real life, not just on paper.
Robert works in a hospital setting, so there’s support for multidisciplinary care when it’s needed. That can matter a lot for people who feel unwell with flares, or who have more than one issue happening at once. At the centre of the work is listening, making sense of confusing symptoms, and checking progress regularly.
There’s also an ongoing effort to stay across newer research in rheumatology, especially when it helps guide care for immune and inflammatory conditions. Clinical trials can be relevant for some patients depending on their diagnosis, but the focus stays on what fits each person’s situation and safety first.
